CCVTF yields 4.37% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CCVTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCVTF + PFE for your $10,000?
China Conch Venture Holdings Limited, an investment holding company, provides various solutions for energy conservation and environmental protection in China, the rest of Asia, the Asia-Pacific, and South America. The company operates through Waste to Energy Project, Port Logistics Services, New Building Materials, and Investments segments. It manufactures and sells residual heat power generation, as well as offers vertical mill and related after-sales services. The company also provides port logistics services, including cargo handling, trans-shipment, and warehousing services; and alternative wall building materials, such as cellulose fiber cement sheets, and autoclaved and wood wool cement boards. In addition, it designs and constructs energy preservation and environmental protection projects; designs, sells, and installs energy preservation and environmental protection equipment; and offers construction design and engineering services. China Conch Venture Holdings Limited was incorporated in 2013 and is headquartered in Wuhu, China.
Full CCVTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.